Issue 81, 2018

A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities

Abstract

We report a new highly crystalline 2D π-conjugated hexagonal mesoporous covalent organic framework material, TrzCOF, through the solvothermal polycondensation of 1,3,5-tri(4-formylbiphenyl) benzene [Ph7(CHO)3, TFBPB] with 2,4,6-tris(4-aminophenyl)-1,3,5-triazine (TAPT) and it displayed excellent anticancer activity for human colorectal carcinoma HCT-116 cells.

Graphical abstract: A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities

Associated articles

Supplementary files

Article information

Article type
Communication
Submitted
07 Sept. 2018
Accepted
17 Sept. 2018
First published
17 Sept. 2018

Chem. Commun., 2018,54, 11475-11478

A new triazine based π-conjugated mesoporous 2D covalent organic framework: its in vitro anticancer activities

S. Kanti Das, S. Mishra, K. Manna, U. Kayal, S. Mahapatra, K. Das Saha, S. Dalapati, G. P. Das, A. A. Mostafa and A. Bhaumik, Chem. Commun., 2018, 54, 11475 DOI: 10.1039/C8CC07289B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements